Patrick Gavigan1, Jonathan A McCullers2. 1. Department of Pediatrics, University of Tennessee Health Science Center. 2. Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Abstract
PURPOSE OF REVIEW: Influenza remains a major cause of morbidity and mortality. The 2017-2018 season was one of the most severe in the past decade. The exact factors determining the severity of a particular influenza season are complex and often poorly understood. RECENT FINDINGS: Factors impacting annual influenza severity include characteristics of the specific virus, influenza vaccination, and antiviral use. Although viral virulence factors are important in this context and our knowledge of these is growing, there is a complex interplay between expression of these factors and their impact on a particular patient population. Vaccination has demonstrated efficacy in preventing disease, but vaccination rates remain sub-optimal and vaccine effectiveness can vary significantly between influenza strains and patient populations. Finally, while antiviral treatment is available and has shown benefits, many patients with influenza do not receive treatment. SUMMARY: Strides have been made in recent years towards understanding the many factors that contribute to the severity of any particular influenza season. Obvious areas for improvement include improved vaccination rates and antiviral use. Additionally, a more complete understanding of reasons for poor strain and population-specific vaccine effectiveness may help reduce the severity of future influenza seasons.
PURPOSE OF REVIEW: Influenza remains a major cause of morbidity and mortality. The 2017-2018 season was one of the most severe in the past decade. The exact factors determining the severity of a particular influenza season are complex and often poorly understood. RECENT FINDINGS: Factors impacting annual influenza severity include characteristics of the specific virus, influenza vaccination, and antiviral use. Although viral virulence factors are important in this context and our knowledge of these is growing, there is a complex interplay between expression of these factors and their impact on a particular patient population. Vaccination has demonstrated efficacy in preventing disease, but vaccination rates remain sub-optimal and vaccine effectiveness can vary significantly between influenza strains and patient populations. Finally, while antiviral treatment is available and has shown benefits, many patients with influenza do not receive treatment. SUMMARY: Strides have been made in recent years towards understanding the many factors that contribute to the severity of any particular influenza season. Obvious areas for improvement include improved vaccination rates and antiviral use. Additionally, a more complete understanding of reasons for poor strain and population-specific vaccine effectiveness may help reduce the severity of future influenza seasons.
Authors: Brendon Y Chua; Toshiki Sekiya; Marios Koutsakos; Naoki Nomura; Louise C Rowntree; Thi H O Nguyen; Hayley A McQuilten; Marumi Ohno; Yuki Ohara; Tomohiro Nishimura; Masafumi Endo; Yasushi Itoh; Jennifer R Habel; Kevin J Selva; Adam K Wheatley; Bruce D Wines; P Mark Hogarth; Stephen J Kent; Amy W Chung; David C Jackson; Lorena E Brown; Masashi Shingai; Katherine Kedzierska; Hiroshi Kida Journal: PLoS Pathog Date: 2022-10-07 Impact factor: 7.464
Authors: Kari Ann Shirey; Darren J Perkins; Wendy Lai; Wei Zhang; Lurds R Fernando; Fabian Gusovsky; Jorge C G Blanco; Stefanie N Vogel Journal: mBio Date: 2019-05-07 Impact factor: 7.867
Authors: Felix Broecker; Sean T H Liu; Nungruthai Suntronwong; Weina Sun; Mark J Bailey; Raffael Nachbagauer; Florian Krammer; Peter Palese Journal: NPJ Vaccines Date: 2019-07-19 Impact factor: 7.344
Authors: Veronica G Anania; Adrienne G Randolph; Xiaoying Yang; Allen Nguyen; Margaret M Newhams; W Rodney Mathews; Carrie M Rosenberger; Jacqueline M McBride Journal: Open Forum Infect Dis Date: 2020-04-09 Impact factor: 3.835